Difficulty with swallowing is a potentially serious problem and you should consult your doctor without delay...

Article

Humira (adalimumab)

The funding for Humira treatment for Crohn's disease is a major step forward for treatment in NZ. The criteria is restricted but most patients with moderate to severe disease not responding to azathioprine or methotrexate are now able to gain access to this treatment. The treatment is given as an injection every 2 weeks. This given by a self-injecting pen that is easy to use. The results are excellent but close review by your gastroenterologist is required

designed and developed by QT Web